Regeneron works on UK, S.African Covid variants, says company | Malay Mail

  • 📰 malaymail
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 86%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

WASHINGTON, Jan 28 — Regeneron’s synthetic antibody treatment remains effective against the British and South African variants of the novel coronavirus, the US biotechnology company announced yesterday. The therapy used on ex-president Donald Trump has had emergency approval since November for...

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York September 17, 2020. — Reuters pic

REGEN-COV — featuring potent neutralizing antibodies called imdevimab and casirivimab — remained effective against both variants, the company said in a statement, although casirivimab’s potency against the South African variant was “reduced.” “These data show the continued ability of REGEN-COV to neutralize emerging strains, further validating our multi-antibody cocktail approach to infectious diseases,” said George Yancopoulos, Regeneron’s president and chief scientific officer.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 1. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し